Recombinant Human-Soluble Thrombomodulin Contributes to Reduced Mortality in Sepsis Patients With Severe Respiratory Failure: A Retrospective Observational Study Using a Multicenter Dataset

BACKGROUND: Recombinant human-soluble thrombomodulin (rhTM) is a novel class therapeutic agent for managing disseminated intravascular coagulation. The progression of severe respiratory failure may be related to intra-alveolar coagulation/fibrinolytic disorders. We aimed to determine the efficacy of...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshihiro, Shodai, Sakuraya, Masaaki, Hayakawa, Mineji, Ono, Kota, Hirata, Akira, Takaba, Akihiro, Kawamura, Natsuki, Tsutsui, Toru, Yoshida, Kenichi, Hashimoto, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Clinical Science Aspects
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319596/
https://www.ncbi.nlm.nih.gov/pubmed/29596106
http://dx.doi.org/10.1097/SHK.0000000000001148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319596/
https://www.ncbi.nlm.nih.gov/pubmed/29596106
http://dx.doi.org/10.1097/SHK.0000000000001148

Ejemplares similares